TPBG 靶点蛋白|抗体药物|临床药物信息

TPBG信息

英文名称：Trophoblast glycoprotein
中文名称：5T4滋养层糖蛋白
靶点别称：Trophoblast glycoprotein，5T4 oncotrophoblast glycoprotein，5T4，TPBG，5T4 oncofetal antigen，M6P1，5T4 oncofetal trophoblast glycoprotein，Wnt-Activated Inhibitory Factor 1，WAIF1，5T4AG，5T4-AG

上市药物数量：0
临床药物数量：6
最高研发阶段：临床一期

TPBG产品列表

筛选结果

产品库

在线 (5)

物种

标签

属性

Protein (5)

标记

货号	物种	产品描述
TPG-H82Eb	Human	Biotinylated Human TPBG / 5T4 Protein, His,Avitag™
TPG-H52E5	Human	Unconjugated Human TPBG / 5T4 Protein, His,Avitag™
TPG-C52H3	Cynomolgus / Rhesus macaque	Cynomolgus / Rhesus macaque TPBG / 5T4 Protein, His Tag
TPG-H5253	Human	Human TPBG / 5T4 Protein, Fc Tag (MALS verified)
TPG-M52H3	Mouse	Mouse TPBG / 5T4 Protein, His Tag (MALS verified)

TPG-H82Eb|Biotinylated Human TPBG / 5T4 Protein, His,Avitag™

138XXXXXXX4

1人赞

一直单位每月都有订你们产品，包装盒安全可靠，运输也很快，来货信息跟实物一致完全准确无误，东西安全可靠，值得信赖，相信今后会更加在市场大阔增更大市场。
>
2021-11-11

TPG-H82Eb|Biotinylated Human TPBG / 5T4 Protein, His,Avitag™

139XXXXXXX3

0人赞

第二次购买该抗原，上一次做了结合实验，效果不错，这一次开展亲和力检测，希望一切顺利，到货速度很快，抗原包装完好，溶解方法描述清晰，溶解方法简单，溶解度很好，进行实验非常顺利，质量有保障，还会回购
>
2022-04-01

TPG-H52E5|Unconjugated Human TPBG / 5T4 Protein, His,Avitag™

139XXXXXXX3

0人赞

用于抗体筛选工作，目前方法建立顺利进行中，抗原能很好的溶解和包被，提供的技术支持也比较完善，试验中出现的问题都能给予多方面的支持
>
2022-04-01

TPBG 分子别名

TPBG,5T4,M6P1,5T4AG,WAIF1,5T4 oncofetal antigen,Trophoblast glycoprotein,5T4 oncofetal trophoblast glycoprotein

TPBG 分子背景

Trophoblast glycoprotein (TPBG), also known as 5T4, is the therapeutic target of several anticancer agents currently in clinical development, largely due to its high expression in tumors and low expression in normal adult tissues.This gene encodes a leucine-rich transmembrane glycoprotein that may be involved in cell adhesion. TPBG is expressed by all types of trophoblasts as early as 9 weeks of development.

TPBG 前沿进展

TPBG临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
Prostate cancer vaccine(inactivated viral)(University of Oxford)		临床阶段不明	牛津大学	前列腺癌	详情
OXB-301	OXB-301; SAR-109659		牛津生物医药		详情
ASN-004	ASN-004		Asana Biosciences		详情
SYD-1875	SYD-1875		Synthon Bv		详情
PF-06263507	PF-06263507		牛津生物医药		详情
Naptumomab estafenatox	TTS-CD3; ABR-217620		Active Biotech		详情
Anti-5T4 CAR-raNK Cell Therapy		临床一期	英百瑞（杭州）生物医药有限公司	实体瘤	详情

会议日历

会议一览

TPBG